Startups
Edit

TerSera Therapeutics USA

http://www.jdptherapeutics.com/
Last activity: 28.06.2016
Active - Reference to TerSera Therapeutics USA
Categories: MedtechProductSpecialty
TerSera Therapeutics LLC acquires and develops specialty pharmaceutical products with a focus on select therapeutic areas.
Mentions
3

Overview

Employees
11-50
Total raised
$17M
Founded date
2009

Funding Rounds 1

DateSeriesAmountInvestors
Sign up to seeSign up to seeSign up to seeSign up to see

Mentions in press and media 3

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Mar 14, 2013Biotech startup developing drug to treat acute allergic reactions raises fresh capitalIn home settings, where people would be more likely to suffer from an allergic reaction from food or a bee sting, the standard of care is an injection of epinephrine, followed by a trip to the emergency room where patients would get diphenh...
Biotech startup developing drug to treat acute allergic reactions raises fresh capitalA biotechnology startup is developing a small molecule drug it hopes could offer an alternative to the current standard of care for patients who suffer from an acute allergic reaction in hospital and home settings for the first time in more...

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about TerSera Therapeutics USA

When was TerSera Therapeutics USA founded?

TerSera Therapeutics USA was founded in 2009.

How much funding has TerSera Therapeutics USA raised?

TerSera Therapeutics USA has raised $17M in total across 1 funding round.

What has the press written about TerSera Therapeutics USA?

Parsers VC has collected 3 articles mentioning TerSera Therapeutics USA, among them “Biotech startup developing drug to treat acute allergic reactions raises fresh capital” (Mar 14, 2013) and “Biotech startup developing drug to treat acute allergic reactions raises fresh capital”.

Is TerSera Therapeutics USA still active?

Yes, TerSera Therapeutics USA is active; its latest activity on Parsers VC dates from Jun 28, 2016.